UPMC to add new monoclonal antibody treatment

FDA allowed emergency use of one of the monoclonal antibody therapies, made by Regeneron, not just when symptoms have appeared but when certain types of patients have been exposed to the Covid-19 virus before any symptoms or positive tests.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.